These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28473524)

  • 1. A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.
    Martin P; Tannenbaum C
    BMJ Open; 2017 May; 7(4):e015959. PubMed ID: 28473524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment.
    Martin P; Tannenbaum C
    BMC Geriatr; 2017 Jan; 17(1):37. PubMed ID: 28143413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.
    Tannenbaum C; Martin P; Tamblyn R; Benedetti A; Ahmed S
    JAMA Intern Med; 2014 Jun; 174(6):890-8. PubMed ID: 24733354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Australian general practice patients' decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach.
    Coe A; Gunn J; Allnutt Z; Kaylor-Hughes C
    BMJ Open; 2024 Feb; 14(2):e078179. PubMed ID: 38355180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.
    Martin P; Tamblyn R; Benedetti A; Ahmed S; Tannenbaum C
    JAMA; 2018 Nov; 320(18):1889-1898. PubMed ID: 30422193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives.
    Hürlimann O; Alers D; Hauri N; Leist P; Schneider C; Bolt L; Rodondi N; Aubert CE
    BMC Geriatr; 2024 May; 24(1):396. PubMed ID: 38704540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation.
    Stuijt PJC; Heringa M; van Dijk L; Faber A; Burgers JS; Feenstra TL; Taxis K; Denig P
    BMC Prim Care; 2024 Jun; 25(1):210. PubMed ID: 38862899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMPOWERing Hospitalized Older Adults to Deprescribe Sedative Hypnotics: A Pilot Study.
    Wilson MG; Lee TC; Hass A; Tannenbaum C; McDonald EG
    J Am Geriatr Soc; 2018 Jul; 66(6):1186-1189. PubMed ID: 29492957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people.
    Reeve E; Ong M; Wu A; Jansen J; Petrovic M; Gnjidic D
    Eur J Clin Pharmacol; 2017 Aug; 73(8):927-935. PubMed ID: 28456823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a benzodiazepine deprescribing quality improvement initiative for older adults in primary care.
    Chae S; Lee E; Lindenberg J; Shen K; Anderson TS
    J Am Geriatr Soc; 2024 Apr; 72(4):1234-1241. PubMed ID: 38147454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing in frail older people--Do doctors and pharmacists agree?
    Page AT; Etherton-Beer CD; Clifford RM; Burrows S; Eames M; Potter K
    Res Social Adm Pharm; 2016; 12(3):438-49. PubMed ID: 26453002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Weffald LA; Green AR; Reeve E; Maciejewski ML; Sheehan OC; Wolff JL; Kraus C; Boyd CM
    JAMA Intern Med; 2022 May; 182(5):534-542. PubMed ID: 35343999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
    Farrell B; Richardson L; Raman-Wilms L; de Launay D; Alsabbagh MW; Conklin J
    Res Social Adm Pharm; 2018 Jan; 14(1):18-25. PubMed ID: 28214150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.
    Hui RL; Chang CC; Niu F; Tang YK; Harano D; Deguzman L; Kao DJ; Awsare S; Draves M
    J Manag Care Spec Pharm; 2019 Aug; 25(8):927-934. PubMed ID: 31347983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An educational intervention to reduce the use of potentially inappropriate medications among older adults (EMPOWER study): protocol for a cluster randomized trial.
    Martin P; Tamblyn R; Ahmed S; Tannenbaum C
    Trials; 2013 Mar; 14():80. PubMed ID: 23514019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of an intervention aimed at deprescribing benzodiazepines in a large US healthcare system using patient education materials: a pre/post-observational study with a control group.
    Le TM; Campbell S; Andraos A; Ahlmark P; Hoang H; Isserman S; Goldzweig CL; Mays AM; Bradley K; Keller MS
    BMJ Open; 2024 Apr; 14(4):e080109. PubMed ID: 38569687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit.
    Campbell NL; Perkins AJ; Khan BA; Gao S; Farber MO; Khan S; Wang S; Boustani MA
    J Am Geriatr Soc; 2019 Apr; 67(4):695-702. PubMed ID: 30664239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing in older people.
    Page AT; Potter K; Clifford R; Etherton-Beer C
    Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a deprescribing tool on the use of sedative hypnotics among older patients: study protocol for a cluster randomised controlled trial in Swiss primary care (the HYPE trial).
    Weiss K; Pichierri G; Grischott T; Groth S; Neuner-Jehle S
    BMJ Open; 2023 Sep; 13(9):e075828. PubMed ID: 37730388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.